Kyle Moran - 01 Jan 2022 Form 4 Insider Report for Wave Life Sciences Ltd. (WVE)

Role
Chief Financial Officer
Signature
/s/ Kyle Moran
Issuer symbol
WVE
Transactions as of
01 Jan 2022
Transactions value $
$0
Form type
4
Filing time
04 Jan 2022, 20:19:12
Next filing
18 Feb 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction WVE Share Option (right to buy) Award $0 +175K $0.00 175K 01 Jan 2022 Ordinary Shares 175K $3.14 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to 25% of the shares on January 1, 2023 and vests as to an additional 6.25% of the shares quarterly thereafter until January 1, 2026.